David Einhorn
Greenlight Capital
David Einhorn ROIVANT SCIENCES LTD stake
total: 357
Greenlight Capital ROIV trades
- Total transactions:
- 9
- New positions:
- 1
- Added:
- 4
- Reduced:
- 4
- Held since:
- 2024 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, David Einhorn holds 2,152,669 ROIVANT SCIENCES LTD (ROIV) shares with a market value of roughly $76.18M accounting for 1.95% of the overall portfolio. To date, the estimated cost basis is nearly $10.88 for "buy" trades and estimated average "sell" price is $14.48. Greenlight Capital first purchased ROIV in 2024 Q1, initially acquiring about 4.19M shares. Since the initial investment in ROIVANT SCIENCES LTD (ROIV), Greenlight Capital has made 8 more transactions.
When did David Einhorn buy ROIVANT SCIENCES LTD (ROIV)?
David Einhorn first invested in ROIVANT SCIENCES LTD (ROIV) in 2024 Q1 at the reported quarter-end price of $10.54 per share.
What's the cost basis of Greenlight Capital's ROIV stake?
The estimated cost basis for ROIVANT SCIENCES LTD (ROIV) stake is around $10.88 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.88
- Weighted AVG sell price:
- $14.48
David Einhorn's historical trades in ROIVANT SCIENCES LTD
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.87%
|
2,152,669
|
$27.70
|
$59,628,931
|
+4.03% (+83,360)
|
+0.07%
|
|
2025 Q4
|
1.58%
|
2,069,309
|
$21.70
|
$44,904,005
|
-9.06% (-206,220)
|
-0.18%
|
|
2025 Q3
|
1.35%
|
2,275,529
|
$15.13
|
$34,428,754
|
-50.00% (-2,275,528)
|
-1.48%
|
|
2025 Q2
|
2.21%
|
4,551,057
|
$11.27
|
$51,290,412
|
-16.36% (-890,110)
|
-0.51%
|
|
2025 Q1
|
2.78%
|
5,441,167
|
$10.09
|
$54,901,375
|
+3.23% (+170,100)
|
+0.09%
|
|
2024 Q4
|
3.21%
|
5,271,067
|
$11.83
|
$62,356,723
|
-0.70% (-36,973)
|
-0.02%
|
|
2024 Q3
|
2.55%
|
5,308,040
|
$11.54
|
$61,254,781
|
+10.33% (+497,080)
|
+0.24%
|
|
2024 Q2
|
2.49%
|
4,810,960
|
$10.57
|
$50,851,847
|
+14.81% (+620,470)
|
+0.32%
|
|
2024 Q1
|
2.02%
|
4,190,490
|
$10.54
|
$44,167,765
|
new
|
+2.02%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.